Prot #1368-0104: A Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Spesolimab in the Treatment of Patients with Netherton Syndrome

Project: Research project

Project Details

StatusActive
Effective start/end date12/5/2312/5/24

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1368-0104)